JPH1025251A5 - - Google Patents

Info

Publication number
JPH1025251A5
JPH1025251A5 JP1997054254A JP5425497A JPH1025251A5 JP H1025251 A5 JPH1025251 A5 JP H1025251A5 JP 1997054254 A JP1997054254 A JP 1997054254A JP 5425497 A JP5425497 A JP 5425497A JP H1025251 A5 JPH1025251 A5 JP H1025251A5
Authority
JP
Japan
Prior art keywords
mammal
treating
active ingredient
monoclonal antibody
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997054254A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1025251A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH1025251A publication Critical patent/JPH1025251A/ja
Publication of JPH1025251A5 publication Critical patent/JPH1025251A5/ja
Pending legal-status Critical Current

Links

JP9054254A 1996-02-29 1997-02-24 抗ｔｎｆ抗体による敗血症性シヨツクの治療 Pending JPH1025251A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60902296A 1996-02-29 1996-02-29
US08/609022 1996-02-29

Publications (2)

Publication Number Publication Date
JPH1025251A JPH1025251A (ja) 1998-01-27
JPH1025251A5 true JPH1025251A5 (enExample) 2005-01-20

Family

ID=24439040

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9054254A Pending JPH1025251A (ja) 1996-02-29 1997-02-24 抗ｔｎｆ抗体による敗血症性シヨツクの治療

Country Status (4)

Country Link
EP (1) EP0791360A3 (enExample)
JP (1) JPH1025251A (enExample)
AU (1) AU1487597A (enExample)
CA (1) CA2198316A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022113A1 (de) 2000-05-06 2001-11-15 Daimler Chrysler Ag Hybridantrieb für Kraftfahrzeuge
US20030161828A1 (en) * 2002-02-19 2003-08-28 Abbott Gmbh & Co. Kg Use of TNF antagonists as drugs for the treatment of patients with an inflammatory reaction and without suffering from total organ failure
EP1578799B8 (en) 2002-12-02 2011-03-23 Amgen Fremont Inc. Antibodies directed to tumor necrosis factor and uses thereof
JP5576484B2 (ja) 2010-06-18 2014-08-20 株式会社林原 アデノシンｎ１−オキシドを有効成分として含有する炎症性疾患治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8806339D0 (en) * 1988-03-17 1988-04-13 Hoffmann La Roche Monoclonal antibodies
GB9109645D0 (en) * 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies

Similar Documents

Publication Publication Date Title
FI963101L (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
DK0733628T3 (da) 5-substituerede 3-(1,2,3,6-tetrahydropyridin-4-yl)- og 3-(piperidin-4-yl)-1H-indoler: 5HT1F-agonister
DE69739219D1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
DE69000997D1 (de) Rasch freisetzendes orales teilchenfoermiges pharmazeutisches praeparat, dessen unangenehmer geschmack maskiert ist.
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
FI912952L (fi) Kontrollerbart frigoerande farmaceutiskt preparat.
FI973320A7 (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
JP2002532112A5 (enExample)
NO973612L (no) Nytt farmasöytisk preparat
IL156262A0 (en) Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same
CA2348026A1 (en) Antibodies against semp1, methods for their production and uses thereof
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
MA26455A1 (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
JP2004500325A5 (enExample)
EP1354896A4 (en) NEW MONOCLONAL ANTIBODY
JPH1025251A5 (enExample)
NO973610D0 (no) Nytt farmasöytisk preparat
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
ITMI20001848A0 (it) Faramaci per l'incontinenza.
IS6143A (is) Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni
ITFI940009A0 (it) Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono.
NO973611D0 (no) Nytt farmasöytisk preparat
DZ3039A1 (fr) Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.